KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 111 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $160,800 | -83.4% | 120,000 | -77.8% | 0.01% | -82.9% |
Q2 2023 | $966,138 | -45.2% | 539,742 | +96.8% | 0.04% | -63.9% |
Q4 2021 | $1,763,000 | +424.7% | 274,243 | +375.1% | 0.10% | +470.6% |
Q3 2021 | $336,000 | -96.8% | 57,726 | -94.3% | 0.02% | -95.8% |
Q2 2021 | $10,371,000 | -25.9% | 1,004,962 | -24.5% | 0.40% | -10.7% |
Q1 2021 | $14,003,000 | +245.6% | 1,331,104 | +408.6% | 0.45% | +118.4% |
Q4 2020 | $4,052,000 | +16.5% | 261,729 | +9.9% | 0.21% | -12.7% |
Q3 2020 | $3,477,000 | +81.3% | 238,104 | +135.2% | 0.24% | +98.3% |
Q2 2020 | $1,918,000 | +253.2% | 101,249 | +257.9% | 0.12% | +83.1% |
Q1 2020 | $543,000 | -15.6% | 28,290 | -15.6% | 0.06% | +41.3% |
Q4 2019 | $643,000 | -78.4% | 33,535 | -89.2% | 0.05% | -79.4% |
Q3 2019 | $2,978,000 | – | 309,579 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |